Eurofins Scientific SE Stock
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Euronext Paris
11:12:55 2026-08-20 am EDT
|
5-day change | 1st Jan Change | ||
| 72.84 EUR | +3.09% |
|
+3.91% | +16.73% |
| Jul. 23 | Eurofins Scientific SE, H1 2026 Earnings Call, Jul 23, 2026 | |
| Jul. 23 | Eurofins Scientific: BioPharma's slowdown raises questions on 2026 organic growth target |  |
| Market Cap | 12.27B 14.3B 11.45B 10.51B 19.76B 1,367B 20.09B 135B 52.92B 686B 53.69B 52.53B 2,267B | P/E 2026 * |
23.6x | P/E 2027 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 15.62B 18.2B 14.58B 13.38B 25.16B 1,740B 25.57B 172B 67.37B 873B 68.35B 66.87B 2,885B | EV / Sales 2026 * |
2.06x | EV / Sales 2027 * | 1.91x |
| Free-Float |
60.39% | Yield 2026 * |
1.14% | Yield 2027 * | 1.3% |
Last Transcript: Eurofins Scientific SE
| 1 day | +2.46% | ||
| 1 week | +3.28% | ||
| Current month | +6.22% | ||
| 1 month | +1.83% | ||
| 3 months | +16.55% | ||
| 6 months | +7.20% | ||
| Current year | +16.03% |
| 1 week | 68.62 |  | 72.66 |
| 1 month | 64.56 | | 72.66 |
| Current year | 56.84 | | 74.32 |
| 1 year | 54.86 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 1986-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 2014-12-31 |
Christian Wurst
PRN | Corporate Officer/Principal | 54 | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 1986-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 2014-12-31 |
Valérie Hanote
BRD | Director/Board Member | 60 | 1989-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% | ||
| 2/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% | ||
| 2/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.43% | +3.28% | +5.20% | +34.67% | 14.3B | |
| +1.43% | +2.09% | +2.20% | +24.45% | 50.5B | |
| -2.05% | +4.50% | +483.75% | +606.68% | 46.01B | |
| -1.41% | +4.59% | +20.38% | +89.87% | 42.85B | |
| +2.18% | +5.99% | +33.30% | +19.42% | 41.03B | |
| -0.72% | -3.91% | +17.87% | +47.98% | 32.02B | |
| +1.32% | +6.54% | +33.13% | +152.05% | 16.98B | |
| -1.05% | +5.16% | - | - | 17.05B | |
| +0.73% | +4.42% | +84.04% | +46.18% | 13.84B | |
| +1.61% | +5.33% | -2.13% | -29.11% | 13.31B | |
| Average | +0.43% | +2.13% | +75.30% | +110.24% | 28.79B | |
| Weighted average by Cap. | +0.19% | +2.41% | +99.51% | +142.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.59B 8.85B 7.09B 6.5B 12.22B 846B 12.43B 83.61B 32.74B 424B 33.22B 32.49B 1,402B | 8.01B 9.34B 7.48B 6.86B 12.9B 892B 13.12B 88.25B 34.56B 448B 35.06B 34.3B 1,480B |
| Net income | 531M 619M 496M 455M 855M 59.16B 869M 5.85B 2.29B 29.67B 2.32B 2.27B 98.1B | 660M 769M 616M 565M 1.06B 73.51B 1.08B 7.27B 2.85B 36.87B 2.89B 2.82B 122B |
| Net Debt | 3.35B 3.9B 3.13B 2.87B 5.4B 373B 5.48B 36.9B 14.45B 187B 14.66B 14.34B 619B | 3.01B 3.51B 2.81B 2.58B 4.86B 336B 4.94B 33.21B 13B 168B 13.19B 12.9B 557B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-20 | €72.84 | +3.09% | 124,831 |
| 26-08-19 | €70.66 | +1.44% | 210,639 |
| 26-08-18 | €69.66 | -0.49% | 177,190 |
| 26-08-17 | €70.00 | -0.62% | 201,822 |
| 26-08-14 | €70.44 | +0.49% | 129,199 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
